📣 VC round data is live. Check it out!

BrightSpring Health Valuation Multiples

Discover BrightSpring Health's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Ensign Group, Alibaba Health, JD Health, Droga Raia and more.

BrightSpring Health Overview

About BrightSpring Health

BrightSpring Health Services Inc is a home and community-based healthcare services platform, focused on delivering complementary pharmacy and provider services to complex patients. Its platform delivers clinical services and pharmacy solutions across Medicare, Medicaid, and commercially insured populations. Its segments include Pharmacy Solutions, Provider Services, and others. It generates the majority of its revenue from the Pharmacy Solutions segment.


Founded

2017

HQ

United States

Employees

37.0K

Financials (LTM)

Revenue: $14B
EBITDA: $699M

EV

$13B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

BrightSpring Health Financials

BrightSpring Health reported last 12-month revenue of $14B and EBITDA of $699M.

In the same LTM period, BrightSpring Health generated $2B in gross profit, $699M in EBITDA, and $258M in net income.

Revenue (LTM)


BrightSpring Health P&L

In the most recent fiscal year, BrightSpring Health reported revenue of $13B and EBITDA of $618M.

BrightSpring Health is profitable as of last fiscal year, with gross margin of 12%, EBITDA margin of 5%, and net margin of 1%.

See analyst estimates for BrightSpring Health
LTMLast FY202320242025202620272028
Revenue$14B$13B$9B$11B$13B
Gross Profit$2B$2B$1B$2B$2B
Gross Margin16%12%16%14%12%
EBITDA$699M$618M$350M$398M$460M
EBITDA Margin5%5%4%4%4%
EBIT Margin4%4%2%2%2%
Net Profit$258M$191M($155M)($18M)$191M
Net Margin2%1%(2%)(0%)1%
Net Debt-$2B---

Financial data powered by Morningstar, Inc.

BrightSpring Health Stock Performance

BrightSpring Health has current market cap of $12B, and enterprise value of $13B.

Market Cap Evolution


BrightSpring Health's stock price is $59.98.

BrightSpring Health share price decreased by 2.7% in the last 30 days, and increased by 156.1% in the last year.

BrightSpring Health has an EPS (earnings per share) of $0.98.

See more trading valuation data for BrightSpring Health
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$13B$12B-2.7%-2.7%41.6%156.1%$0.98

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

BrightSpring Health Valuation Multiples

BrightSpring Health trades at 1.0x EV/Revenue multiple, and 19.2x EV/EBITDA.

See NTM and 2027E valuation multiples for BrightSpring Health

EV / Revenue (LTM)


BrightSpring Health Financial Valuation Multiples

As of June 2, 2026, BrightSpring Health has market cap of $12B and EV of $13B.

BrightSpring Health has a P/E ratio of 45.1x.

LTMLast FY202320242025202620272028
EV/Revenue1.0x1.0x1.5x1.2x1.0x
EV/EBITDA19.2x21.8x38.5x33.8x29.3x
EV/EBIT25.4x29.7x91.3x65.1x45.5x
EV/Gross Profit6.2x8.9x9.4x8.5x8.9x
P/E45.1x61.0x(75.2x)n/m61.0x
EV/FCF32.4x34.0x97.9x(235.3x)34.1x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified BrightSpring Health Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

BrightSpring Health Margins & Growth Rates

BrightSpring Health grew revenue by 17% and EBITDA by 31% in the last fiscal year.

In the most recent fiscal year, BrightSpring Health reported gross margin of 12%, EBITDA margin of 5%, and net margin of 1%.

See estimated margins and future growth rates for BrightSpring Health

BrightSpring Health Margins

Last FY202420252026202720282029
Gross Margin12%14%12%17%
EBITDA Margin5%4%4%5%
EBIT Margin4%2%2%4%
Net Margin1%(0%)1%2%
FCF Margin3%(1%)3%3%

BrightSpring Health Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth17%28%15%17%
Gross Profit Growth69%11%(4%)69%
EBITDA Growth31%14%15%77%
EBIT Growth40%40%43%114%
Net Profit Growth84%(88%)(1156%)84%
FCF Growth12%(142%)(791%)13%

Data powered by FactSet, Inc. and Morningstar, Inc.

BrightSpring Health Operational KPIs

BrightSpring Health's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.0M for the same period.

BrightSpring Health's Rule of 40 is 22% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

BrightSpring Health's Rule of X is 47% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for BrightSpring Health
LTMLast FY202320242025202620272028
Rule of 4020%22%---
Bessemer Rule of X43%47%---
Revenue per Employee-$0.3M---
Opex per Employee-$0.0M---
Opex to Revenue-9%15%12%9%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

BrightSpring Health Competitors

BrightSpring Health competitors include Ensign Group, Alibaba Health, JD Health, Droga Raia, MatsukiyoCocokara, Chemed, Tsuruha Holdings, Hinge Health, CR Pharmaceutical and Dr. Sulaiman Al Habib.

Most BrightSpring Health public comparables operate across Pharmacies and Long-Term Care.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Ensign Group2.2x2.1x18.8x17.6x
Alibaba Health1.4x1.2x25.9x21.0x
JD Health0.8x0.8x9.6x12.0x
Droga Raia0.9x0.9x11.5x11.4x
MatsukiyoCocokara0.8x0.7x7.6x7.4x
Chemed2.3x2.2x12.7x12.3x
Tsuruha Holdings0.6x0.5x8.9x8.3x
Hinge Health7.8x6.8x38.0x28.6x

This data is available for Pro users. Sign up to see all BrightSpring Health competitors and their valuation data.

Start Free Trial

BrightSpring Health VC Funding History

Before going public, BrightSpring Health raised $335M in total equity funding, across 2 rounds.


BrightSpring Health Funding Rounds

DateStageRaised FromRaisedValuationRev. MultipleDeal Summary
Jun-25Secondary - public-$305M-BrightSpring Health Services (NASDAQ: BTSG) is a publicly traded healthcare company providing pharmacy and provider services across the United States, not a private company undergoing a capital transaction. The company reported full-year 2025 revenue of $12.9 billion, representing 28.2% growth year-over-year, with Adjusted EBITDA of $618 million, up 34.2% from the prior year. In October 2025, BrightSpring repurchased 1.5 million shares for approximately $43.2 million in connection with a secondary offering by affiliates of Kohlberg Kravis Roberts & Co. and certain members of management; this was a share buyback of existing stock, not a private fundraising round or valuation event. The company operates through two segments: Pharmacy Solutions (which includes infusion and specialty services) and Provider Services (including home health care, rehabilitation, and personal care), serving Medicare, Medicaid, and insured populations. For 2026, management issued guidance of $14.45 billion to $15.0 billion in revenue and $760 million to $790 million in Adjusted EBITDA.
Sep-24Secondary - publicKKR$30M-BrightSpring Health Services is a Louisville-based provider of home- and community-based healthcare services, including home care, home health, hospice, and pharmacy services for complex populations such as seniors and those with behavioral needs. The company operates in all 50 states, serving over 400,000 patients daily through approximately 10,000 clinical providers and pharmacists. On September 13, 2024, funds managed by KKR entered an agreement to acquire a 6.78% stake in BrightSpring Health from Walgreens Boots Alliance, with the transaction expected to close on September 16, 2024. KKR, an existing investor since its 2019 acquisition of BrightSpring alongside Walgreens for $1.32 billion, is doubling down on its position as Walgreens exits. The deal involved purchasing 11,619,998 shares, underscoring KKR's confidence in BrightSpring's growth in the home-based care sector. BrightSpring went public in early 2024 via an IPO raising approximately $880 million at a fully diluted valuation over $3 billion at the midpoint, followed by a $400 million tangible equity units offering. For the 12 months ended September 30, 2023, the company reported $8.4 billion in revenue. Post-IPO, it has focused on integrated care models, with leadership emphasizing enhanced transitions between home health, hospice, personal care, and therapy services.

Acquisitions by BrightSpring Health

BrightSpring Health has acquired 3 companies to date.

Last acquisition by BrightSpring Health was on June 24th 2024. BrightSpring Health acquired Haven for $60M (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by BrightSpring Health

Haven
Abode Healthcare
Advanced Home Care
Description
Haven Hospice is a provider of palliative care services supporting patients, families, and healthcare providers facing advanced illnesses.
Abode Healthcare is a provider of home health and hospice services across 10 U.S. states including Texas and Oklahoma. Acquired by Amedisys in 2021, it operates 20 agencies serving over 5,000 patients annually with skilled nursing, therapy, and palliative care. The firm tailors plans to individual needs in growing markets like the Southeast, emphasizing personalized attention and family support.
Advanced Home Care is the largest Medicare- and Medicaid-certified home health organization in the Southeast United States, headquartered in Georgia. It delivers skilled nursing, physical therapy, occupational therapy, speech therapy, home health aides, and medical social services to patients across multiple states. The provider supports recovery from hospital stays, chronic conditions, and palliative care needs.
HQ CountryUnited StatesUnited StatesUnited States
HQ City
Gainesville, FL
Durango, CO
Greensboro, NC
Deal Date24 Jun 202416 Apr 20216 Mar 2020
Valuation$60M$775Mundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all BrightSpring Health acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About BrightSpring Health

When was BrightSpring Health founded?BrightSpring Health was founded in 2017.
Where is BrightSpring Health headquartered?BrightSpring Health is headquartered in United States.
How many employees does BrightSpring Health have?As of today, BrightSpring Health has over 37K employees.
Who is the CEO of BrightSpring Health?BrightSpring Health's CEO is Jon B. Rousseau.
Is BrightSpring Health publicly listed?Yes, BrightSpring Health is a public company listed on Nasdaq.
What is the stock symbol of BrightSpring Health?BrightSpring Health trades under BTSG ticker.
When did BrightSpring Health go public?BrightSpring Health went public in 2024.
Who are competitors of BrightSpring Health?BrightSpring Health main competitors include Ensign Group, Alibaba Health, JD Health, Droga Raia, MatsukiyoCocokara, Chemed, Tsuruha Holdings, Hinge Health, CR Pharmaceutical, Dr. Sulaiman Al Habib.
What is the current market cap of BrightSpring Health?BrightSpring Health's current market cap is $12B.
What is the current revenue of BrightSpring Health?BrightSpring Health's last 12 months revenue is $14B.
What is the current revenue growth of BrightSpring Health?BrightSpring Health revenue growth (NTM/LTM) is 15%.
What is the current EV/Revenue multiple of BrightSpring Health?Current revenue multiple of BrightSpring Health is 1.0x.
What is the current EBITDA of BrightSpring Health?BrightSpring Health's last 12 months EBITDA is $699M.
What is BrightSpring Health's EBITDA margin?BrightSpring Health's last 12 months EBITDA margin is 5%.
What is the current EV/EBITDA multiple of BrightSpring Health?Current EBITDA multiple of BrightSpring Health is 19.2x.
What is the current FCF of BrightSpring Health?BrightSpring Health's last 12 months FCF is $415M.
What is BrightSpring Health's FCF margin?BrightSpring Health's last 12 months FCF margin is 3%.
What is the current EV/FCF multiple of BrightSpring Health?Current FCF multiple of BrightSpring Health is 32.4x.
How many companies BrightSpring Health has acquired to date?As of June 2026, BrightSpring Health has acquired 3 companies.
What was the largest acquisition by BrightSpring Health?$775M acquisition of Abode Healthcare on 16th April 2021 was the largest M&A BrightSpring Health has done to date.
What companies BrightSpring Health acquired?BrightSpring Health acquired Abode Healthcare, Haven, and Advanced Home Care.
In how many companies BrightSpring Health has invested to date?BrightSpring Health hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to BrightSpring Health

Lists including BrightSpring Health

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial